Join us as we celebrate the Lunar New Year and support vital kids' cancer research Find out more
Our expert Research Advisory Committee (RAC) independently review and rate all grant submissions. Their recommendations are handed to The Kids’ Cancer Project Board who ultimately determine the studies funded. The rules of the peer review process prohibit RAC members endorsing their own projects.
Dr Cripe is a paediatric specialist at Nationwide Children’s Hospital in Columbus, Ohio. His clinical expertise includes gene and viral therapies for paediatric solid tumours, including brain tumours, neuroblastoma, and bone and soft tissue sarcomas. His research focuses on developing and testing targeted therapies for childhood cancers and translating these discoveries into clinical practice.
Professor Norris was among the first three scientists to establish the Children’s Cancer Institute when its research labs opened in 1984. He leads the Molecular Diagnostics Program and has served as Deputy Director since 2000. He is also the inaugural Director of the UNSW Centre for Childhood Cancer Research, advancing innovative treatments for childhood cancer.
Dr Weigel is Director of the Division of Paediatric Haematology/Oncology at Masonic Cancer Centre, University of Minnesota. A professor at U of M’s Cancer Centre and Department of Paediatrics, she holds the Lehman/Children’s Cancer Research Fund Endowed Chair in Paediatric Cancer. She also chairs Developmental Therapeutics for the Children’s Oncology Group.
Professor Izant has extensive global experience in biomedical research, business, and non-profit leadership. He has worked at Yale School of Medicine, Garvan Institute, QUT, Johnson & Johnson, and the Bill & Melinda Gates Foundation. He has helped establish biotech and bioinformatics companies and has served on multiple government and private research funding committees.
Associate Professor Moore is a Senior Staff Specialist in Paediatric Oncology at Queensland Children’s Hospital, where he directs Clinical and Biomedical Research. He specialises in childhood leukaemia, particularly acute myeloid leukaemia (AML). He holds an academic title with The University of Queensland’s Faculty of Medicine and leads the Queensland Children's Tumour Bank.
Dr McLoone is a senior research fellow in the Behavioural Sciences Unit, Australia's largest paediatric psycho-oncology research group. She holds positions at UNSW Sydney and the Kids Cancer Centre, Sydney Children's Hospital. Her research explores the psychosocial impact of childhood cancer, and she is actively involved in international initiatives and telehealth innovation.
Dr Stehn is the Integrative Oncology and Supportive Care Research Manager at Chris O’Brien Lifehouse Comprehensive Cancer Hospital. With over 25 years’ experience in academic and industry health sectors, she specialises in translational and clinical research. Her work focuses on developing treatment strategies that enhance both the quality and duration of life for cancer patients.
Associate Professor Ziegler is a senior Staff Specialist at the Kids Cancer Centre, Sydney Children’s Hospital, Randwick. A paediatric oncologist with expertise in neuro-oncology and early phase clinical trials, he also leads a research group at the Children’s Cancer Institute and is a conjoint Associate Professor at UNSW Sydney.
